Publications by authors named "Kayode Solomon Adedapo"

Objective: The use of radionuclides in patients undergoing nuclear medicine procedures presents a special concern on the safety of not only the patients but also of those who come in contact with such patients either at the nuclear medicine centre or at home after discharge from the facility. This has heightened the public concern about nuclear medicine especially in Nigeria where the practice is new. When patients are injected with radioactivity for nuclear medicine procedures they excrete most of the radioactivity via urine even before leaving the nuclear medicine facility.

View Article and Find Full Text PDF

The role of nuclear medicine in disease management in a developing nation is as impactful as it is in other regions of the world. However, in the developing world, the practice of nuclear medicine is faced with a myriad of challenges, which can be easily avoided. In this review, we examine the many avoidable challenges to the practice of nuclear medicine in a developing nation.

View Article and Find Full Text PDF

Objective: Using radioactive iodine (RAI) as the first line therapy for Graves' hyperthyroidism and as the treatment of choice for relapsed Graves' disease is increasing in recent times. However, there has been little consensus on the most appropriate dose to use. So this study is to determine the response of hyperthyroidism to fixed doses of 370 MBq and 555 MBq RAI therapies and determine the incidence of hypothyroidism at 6 months post therapy.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate the prevalence and risk factors associated with gestational diabetes mellitus (GDM) at University College Hospital in Ibadan, Nigeria.
  • Over a two-year period, records of 765 women referred for oral glucose tolerance testing were analyzed, revealing a crude prevalence rate of 13.9%, with most diagnoses occurring in the third trimester.
  • Key risk factors for GDM included a positive family history of diabetes, age over 30, and significant fasting glucose levels; importantly, there was no identified BMI threshold as a risk factor for women in their first trimester.
View Article and Find Full Text PDF